ClinConnect ClinConnect Logo
Search / Trial NCT01493349

Pathophysiology of Diverticular Disease

Launched by MAASTRICHT UNIVERSITY MEDICAL CENTER · Dec 14, 2011

Trial Information

Current as of May 07, 2025

Unknown status

Keywords

Colonic Diverticula Diverticulitis

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 50 years and ≤ 75 years
  • Scheduled for colonoscopy
  • Written informed consent
  • Patient group: The presence of diverticulosis, diagnosed during the scheduled colonoscopy
  • Control group: During the scheduled colonoscopy, diverticulosis or other
  • gastrointestinal and liver diseases are absent. In other words, the
  • colonoscopy is qualified as a 'normal' colonoscopy.
  • Exclusion Criteria:
  • Age \< 18 years
  • Presence of gastrointestinal and liver diseases, such as inflammatory bowel disease.
  • Use of NSAID's and proton pump inhibitors, during the 5-day time period prior to endoscopy.
  • Alcohol intake above 14 consumptions per week for males and 7 consumption per week for females
  • (Sub)total colectomy or hemicolectomy.
  • Refusal to participate in this study

About Maastricht University Medical Center

Maastricht University Medical Center (MUMC+) is a leading academic medical center in the Netherlands, renowned for its commitment to advancing healthcare through innovative research and education. As a prominent sponsor of clinical trials, MUMC+ integrates cutting-edge scientific inquiry with clinical practice, focusing on a wide range of medical disciplines. The center emphasizes collaboration among multidisciplinary teams, fostering an environment that promotes excellence in patient care and the translation of research findings into clinical applications. MUMC+ is dedicated to improving health outcomes and enhancing quality of life through rigorous clinical investigations and the development of novel therapeutic strategies.

Locations

Maastricht, Limburg, Netherlands

Patients applied

0 patients applied

Trial Officials

A. M. Masclee, MD, PhD

Principal Investigator

Maastricht University Medical Center

D. Jonkers, PhD

Study Chair

Maastricht University Medical Center

R. C. Deutz, MD

Study Chair

Maastricht University Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials